Tropanserin (INN; MDL-72,422) is a drug which acts as a potent and selective 5-HT3 receptor antagonist.[1] It was investigated in clinical trials for the treatment of migraine in the 1980s but was never marketed.[2]
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
CompTox Dashboard (EPA) |
|
Chemical and physical data | |
Formula | C17H23NO2 |
Molar mass | 273.376 g·mol−1 |
3D model (JSmol) |
|
| |
|
Tropanserin can be prepared by the reaction of tropine with 3,5-dimethylbenzoyl chloride.